Summit Therapeutics Inc.
Summit Therapeutics Inc. (SMMT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
smmt · stock forecast · 21 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 21 Wall Street analysts in the past 3 months
Buy
21 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$23.00
Consensus
$19.00
+28.9% upside
Low
$16.00
Median: $18 · Last Close: $14.74
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$19.00
28.9% upside
High Target
$23
56.0%
Low Target
$16
8.5%
Current Price
$14.74
as of today
Based on analyst price targets, the SMMT stock price prediction for the next 12 months ranges from $16 to $23. The consensus SMMT price forecast of $19.00 implies 28.9% upside from the current price of $14.74.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.00 | ↓ 5.00% |
1-day model range: $13.84–$14.17. Peak: $14.17 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +22.9% |
| 2028 | $21 | +41.1% |
| 2029 | $23 | +54.8% |
| 2030 | $24 | +64.5% |
| 2031 | — | +71.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SMMT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-01 | Piper Sandler | Maintains | Neutral→Neutral |
| 2026-04-08 | Stifel | Maintains | Buy→Buy |
| 2026-03-16 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-30 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-17 | Barclays | Upgrade ↑ | Underweight→Equal Weight |
| 2025-10-22 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Summit Therapeutics Inc. (SMMT) stock. Of the recent 59 rating actions, 2 were upgrades and 8 were downgrades. 21 analysts currently cover SMMT.
Analyst Recommendation Trends
SMMT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$4M
↓ 99.5% YoY
Revenue Next Year
$78M
↑ 1973.8% YoY
EPS This Year
$-1.13
EPS Next Year
$-1.13
↑ 0.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast SMMT EPS of $-1.13 for the current fiscal year, based on estimates from 8 analysts. The SMMT revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SMMT stock forecast is supported by two independent data sources: analyst consensus ratings from 21 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SMMT price target is $19.00 (+28.9% upside), with an analyst consensus of Buy.
The SMMT short-term stock prediction for tomorrow is $14.00 (-5.00%). The SMMT stock price prediction for 2027 estimates an average of $18. The SMMT stock prediction for 2030 projects a range of $21–$27.
Summit Therapeutics Inc. trades on NASDAQ under the ticker SMMT. The SMMT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
SMMT forecast · 8 questionsAccording to 21 Wall Street analysts, the average 12-month SMMT price target is $19.00, with a high forecast of $23.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies +28.9% potential upside from the current price of $14.74.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.